1	Señale	señalar	VMM03S0	-	-	449-455	598_QUEST_clinical_caseMIR	SENT1	-	-
2	la	el	DA0FS0	-	-	456-458	598_QUEST_clinical_caseMIR	SENT1	-	-
3	afirmación	afirmación	NCFS000	-	-	459-469	598_QUEST_clinical_caseMIR	SENT1	-	-
4	correcta	correcto	AQ0FS0	C0205170	calificador	470-478	598_QUEST_clinical_caseMIR	SENT1	-	-
5	:	:	Fd	-	-	478-479	598_QUEST_clinical_caseMIR	SENT1	-	-
6	Hombre	hombre	NCMS000	C0025266#C0086418#C0043210	persona#organismo_vivo	0-6	598_QUEST_clinical_caseMIR	SENT1	-	-
7	de	de	SPS00	C0332285	atributo	7-9	598_QUEST_clinical_caseMIR	SENT1	-	-
8	45	45		-	-	10-12	598_QUEST_clinical_caseMIR	SENT1	-	-
9	años	año	NCMP000	C0439234	calificador	13-17	598_QUEST_clinical_caseMIR	SENT1	-	-
10	con	con	SPS00	C0332287	atributo	18-21	598_QUEST_clinical_caseMIR	SENT1	-	-
11	insuficiencia	insuficiencia	NCFS000	C0403447_1	trastorno_1	22-35	598_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
12	renal	renal	AQ0CS0	C0403447_2	trastorno_2	36-41	598_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
13	crónica	crónico	AQ0FS0	C0403447_3	trastorno_3	42-49	598_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
14	secundaria	secundario	AQ0FS0	C0175668	calificador	50-60	598_QUEST_clinical_caseMIR	SENT1	-	-
15	a	a	SPS00	-	-	61-62	598_QUEST_clinical_caseMIR	SENT1	-	-
16	nefropatía	nefropatía	NCFS000	C0011881_1	trastorno_1	63-73	598_QUEST_clinical_caseMIR	SENT1	B-Grp_Enfermedad	-
17	diabética	diabético	NCFS000	C0011881_2	trastorno_2	74-83	598_QUEST_clinical_caseMIR	SENT1	B-Calificador	-
18	que	que	PR0CN000	-	-	84-87	598_QUEST_clinical_caseMIR	SENT1	-	-
19	recibe	recibir	VMIP3S0	-	-	88-94	598_QUEST_clinical_caseMIR	SENT1	-	-
20	un	un		C0205447_1	calificador_1	95-97	598_QUEST_clinical_caseMIR	SENT1	-	-
21	trasplante	trasplante	NCMS000	C0022671_1	procedimiento_1	98-108	598_QUEST_clinical_caseMIR	SENT1	-	-
22	renal	renal	AQ0CS0	C0022671_2	procedimiento_2	109-114	598_QUEST_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
23	de	de	SPS00	C0332285	atributo	115-117	598_QUEST_clinical_caseMIR	SENT1	-	-
24	donante	donante	NCCS000	C0013018	calificador	118-125	598_QUEST_clinical_caseMIR	SENT1	-	-
25	fallecido	fallecer	VMP00SM	-	-	126-135	598_QUEST_clinical_caseMIR	SENT1	-	-
26	.	.	Fp	-	-	135-136	598_QUEST_clinical_caseMIR	SENT1	-	-

1	Se	se	P00CN000	-	-	137-139	598_QUEST_clinical_caseMIR	SENT2	-	-
2	establece	establecer	VMIP3S0	-	-	140-149	598_QUEST_clinical_caseMIR	SENT2	-	-
3	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	150-161	598_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
4	inmunosupresor	inmunosupresor	AQ0MS0	C0021081	producto#sustancia	162-176	598_QUEST_clinical_caseMIR	SENT2	I-Grp_Medicamento	-
5	con	con	SPS00	C0332287	atributo	177-180	598_QUEST_clinical_caseMIR	SENT2	-	-
6	triple	triple	AQ0CS0	C0205174	calificador	181-187	598_QUEST_clinical_caseMIR	SENT2	-	-
7	terapia	terapia	NCFS000	C0087111	régimen/tratamiento	188-195	598_QUEST_clinical_caseMIR	SENT2	-	-
8	estándar	estándar	AQ0CS0	-	-	196-204	598_QUEST_clinical_caseMIR	SENT2	-	-
9	con	con	SPS00	C0332287	atributo	205-208	598_QUEST_clinical_caseMIR	SENT2	-	-
10	esteroides	esteroide	NCMP000	C0301818#C0038317	sustancia	209-219	598_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
11	,	,	Fc	-	-	219-220	598_QUEST_clinical_caseMIR	SENT2	-	-
12	tacrolimus	tacrolimus	NC00SC0	C0085149	producto#sustancia	221-231	598_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
13	y	y	CC	C1706368	calificador	232-233	598_QUEST_clinical_caseMIR	SENT2	-	-
14	micofenolato	micofenolato	NCMS000	-	-	234-246	598_QUEST_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
15	.	.	Fp	-	-	246-247	598_QUEST_clinical_caseMIR	SENT2	-	-

1	Cursa	cursar	VMIP3S0	-	-	248-253	598_QUEST_clinical_caseMIR	SENT3	-	-
2	con	con	SPS00	C0332287	atributo	254-257	598_QUEST_clinical_caseMIR	SENT3	-	-
3	función	función	NCFS000	C0542341	entidad_observable#atributo	258-265	598_QUEST_clinical_caseMIR	SENT3	-	-
4	inmediata	inmediato	AQ0FS0	C0205253	calificador	266-275	598_QUEST_clinical_caseMIR	SENT3	-	-
5	del	del	SP+DA	-	-	276-279	598_QUEST_clinical_caseMIR	SENT3	-	-
6	injerto	injerto	NCMS000	C0040732#C1961139#C0181074#C0332835#C0021102	procedimiento#calificador#sustancia#estructura_corporal#objeto_físico	280-287	598_QUEST_clinical_caseMIR	SENT3	-	-
7	descendiendo	descender	VMG0000	-	-	288-300	598_QUEST_clinical_caseMIR	SENT3	-	-
8	las	el	DA0FP0	-	-	301-304	598_QUEST_clinical_caseMIR	SENT3	-	-
9	cifras	cifra	NCFP000	-	-	305-311	598_QUEST_clinical_caseMIR	SENT3	-	-
10	de	de	SPS00	C0332285	atributo	312-314	598_QUEST_clinical_caseMIR	SENT3	-	-
11	creatinina	creatinina	NC00SC0	C0010294	sustancia	315-325	598_QUEST_clinical_caseMIR	SENT3	-	-
12	sérica	sérico	AQ0FS0	-	-	326-332	598_QUEST_clinical_caseMIR	SENT3	-	-
13	hasta	hasta	SPS00	-	-	333-338	598_QUEST_clinical_caseMIR	SENT3	-	-
14	1,5	1.5	Z	-	-	339-342	598_QUEST_clinical_caseMIR	SENT3	-	-
15	mg	mg	NCMN000	-	-	343-345	598_QUEST_clinical_caseMIR	SENT3	-	-
16	/	/	Fh	-	-	345-346	598_QUEST_clinical_caseMIR	SENT3	-	-
17	dL	decilitro	NCMN000	C0439241	calificador	346-348	598_QUEST_clinical_caseMIR	SENT3	-	-
18	en	en	SPS00	C1720294#C0332285	calificador#atributo	349-351	598_QUEST_clinical_caseMIR	SENT3	-	-
19	la	el	DA0FS0	-	-	352-354	598_QUEST_clinical_caseMIR	SENT3	-	-
20	primera	1	AO0FS0	-	-	355-362	598_QUEST_clinical_caseMIR	SENT3	-	-
21	semana	semana	NCFS000	C0439230	calificador	363-369	598_QUEST_clinical_caseMIR	SENT3	-	-
22	postrasplante	postrasplante	NCMS000	-	-	370-383	598_QUEST_clinical_caseMIR	SENT3	-	-
23	.	.	Fp	-	-	383-384	598_QUEST_clinical_caseMIR	SENT3	-	-

1	Diez	Diez		-	-	385-389	598_QUEST_clinical_caseMIR	SENT4	-	-
2	días	día	NCMP000	C0439228#C0332169	calificador	390-394	598_QUEST_clinical_caseMIR	SENT4	-	-
3	después	después	RG	C0231290	atributo	395-402	598_QUEST_clinical_caseMIR	SENT4	-	-
4	se	se	P00CN000	-	-	403-405	598_QUEST_clinical_caseMIR	SENT4	-	-
5	observa	observar	VMIP3S0	-	-	406-413	598_QUEST_clinical_caseMIR	SENT4	-	-
6	un	un		C0205447_1	calificador_1	414-416	598_QUEST_clinical_caseMIR	SENT4	-	-
7	deterioro	deterioro	NCMS000	C1265875#C0684336#C0231171	anomalía_morfológica#hallazgo	417-426	598_QUEST_clinical_caseMIR	SENT4	B-Grp_Enfermedad	-
8	agudo	agudo	AQ0MS0	C0205178	calificador	427-432	598_QUEST_clinical_caseMIR	SENT4	B-Calificador	-
9	de	de	SPS00	C0332285	atributo	433-435	598_QUEST_clinical_caseMIR	SENT4	B-Calificador	-
10	función	función	NCFS000	C0232804_1	entidad_observable_1	436-443	598_QUEST_clinical_caseMIR	SENT4	I-Calificador	-
11	renal	renal	AQ0CS0	C0232804_2	entidad_observable_2	444-449	598_QUEST_clinical_caseMIR	SENT4	I-Calificador	-
12	con	con	SPS00	C0332287	atributo	450-453	598_QUEST_clinical_caseMIR	SENT4	-	-
13	aumento	aumento	NCMS000	C0442805	calificador	454-461	598_QUEST_clinical_caseMIR	SENT4	-	-
14	de	de	SPS00	C0332285	atributo	462-464	598_QUEST_clinical_caseMIR	SENT4	-	-
15	creatinina	creatinina	NC00SC0	C0010294	sustancia	465-475	598_QUEST_clinical_caseMIR	SENT4	-	-
16	hasta	hasta	SPS00	-	-	476-481	598_QUEST_clinical_caseMIR	SENT4	-	-
17	2,5	2.5	Z	-	-	482-485	598_QUEST_clinical_caseMIR	SENT4	-	-
18	mg	mg	NCMN000	-	-	486-488	598_QUEST_clinical_caseMIR	SENT4	-	-
19	/	/	Fh	-	-	488-489	598_QUEST_clinical_caseMIR	SENT4	-	-
20	dL	decilitro	NCMN000	C0439241	calificador	489-491	598_QUEST_clinical_caseMIR	SENT4	-	-
21	.	.	Fp	-	-	491-492	598_QUEST_clinical_caseMIR	SENT4	-	-

1	¿	¿	Fia	-	-	493-494	598_QUEST_clinical_caseMIR	SENT5	-	-
2	Cuál	cuál	PT0CS000	-	-	494-498	598_QUEST_clinical_caseMIR	SENT5	-	-
3	de	de	SPS00	C0332285	atributo	499-501	598_QUEST_clinical_caseMIR	SENT5	-	-
4	los	el	DA0MP0	-	-	502-505	598_QUEST_clinical_caseMIR	SENT5	-	-
5	siguientes	siguiente	AQ0CP0	C0332282	atributo	506-516	598_QUEST_clinical_caseMIR	SENT5	-	-
6	diagnósticos	diagnóstico	NCMP000	C0011900	entidad_observable	517-529	598_QUEST_clinical_caseMIR	SENT5	-	-
7	seria	serio	AQ0FS0	C0205404	calificador	530-535	598_QUEST_clinical_caseMIR	SENT5	-	-
8	el	el	DA0MS0	-	-	536-538	598_QUEST_clinical_caseMIR	SENT5	-	-
9	MENOS	menos	RG	C0332288	atributo	539-544	598_QUEST_clinical_caseMIR	SENT5	-	-
10	probable	probable	AQ0CS0	C0332148	calificador	545-553	598_QUEST_clinical_caseMIR	SENT5	-	-
11	?	?	Fit	-	-	553-554	598_QUEST_clinical_caseMIR	SENT5	-	-

